| |
 |
|
Class Information
Number: 514/49
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring > Pyrimidines (including hydrogenated) (e.g., cytosine, etc.)
Description: Subject matter wherein the hetero ring is a pyrimidine, as illustrated below, or substituted pyrimidine.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618950 |
Method for treatment and prevention of herpes zoster by topical application |
Nov. 17, 2009 |
| 7615539 |
Nucleic acid-lipophilic conjugates |
Nov. 10, 2009 |
| 7612047 |
Degradation-resistant mononucleoside phosphate compounds |
Nov. 3, 2009 |
| 7608597 |
Methods and compositions for treating hepatitis C virus |
Oct. 27, 2009 |
| 7608602 |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
Oct. 27, 2009 |
| 7608600 |
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Oct. 27, 2009 |
| 7601702 |
Dutpase Inhibitors |
Oct. 13, 2009 |
| 7589077 |
Antiviral nucleosides |
Sep. 15, 2009 |
| 7589078 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections |
Sep. 15, 2009 |
| 7589079 |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Sep. 15, 2009 |
| 7585851 |
3'-prodrugs of 2'-deoxy-.beta.-L-nucleosides |
Sep. 8, 2009 |
| 7582619 |
Compositions and methods for treatment of mitochondrial diseases |
Sep. 1, 2009 |
| 7582618 |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
Sep. 1, 2009 |
| 7560442 |
Pharmaceutically active uridine esters |
Jul. 14, 2009 |
| 7557093 |
Composition for promoting collagen production |
Jul. 7, 2009 |
| 7550442 |
Nucleoside analog inhibitors of reverse transcriptase |
Jun. 23, 2009 |
| 7547704 |
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Jun. 16, 2009 |
| 7531525 |
P.sup.1-(2'-deoxycytidine 5'-)P.sup.4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis |
May. 12, 2009 |
| 7524831 |
Treatments for Flaviviridae virus infection |
Apr. 28, 2009 |
| 7488721 |
Real time methylumbelliferone-based assay |
Feb. 10, 2009 |
| 7465734 |
Methods and compositions for overcoming resistance to biologic and chemotherapy |
Dec. 16, 2008 |
| 7456155 |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
Nov. 25, 2008 |
| 7432272 |
Antiviral analogs |
Oct. 7, 2008 |
| 7429572 |
Modified fluorinated nucleoside analogues |
Sep. 30, 2008 |
| 7419967 |
Sulfonamide inhibitors of aspartyl protease |
Sep. 2, 2008 |
| 7419966 |
[5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
Sep. 2, 2008 |
| 7417034 |
Pharmaceutically active uridine esters |
Aug. 26, 2008 |
| 7405214 |
Nucleoside derivatives and therapeutic use thereof |
Jul. 29, 2008 |
| 7396826 |
Pharmaceutically active uridine esters |
Jul. 8, 2008 |
| 7384924 |
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Jun. 10, 2008 |
| 7378401 |
Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases |
May. 27, 2008 |
| 7378402 |
Anti-viral nucleosides |
May. 27, 2008 |
| 7375081 |
Therapeutic combination of a pneumocandin derivative and an antifungal agent |
May. 20, 2008 |
| 7374783 |
Powders coated with specific lipoamino acid composition and cosmetics containing the same |
May. 20, 2008 |
| 7357930 |
Methods and formulations for targeting infectious agents bearing host cell proteins |
Apr. 15, 2008 |
| 7354906 |
Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human |
Apr. 8, 2008 |
| 7323452 |
Method for the accelerated in vivo removal of ethanol |
Jan. 29, 2008 |
| 7309696 |
Compositions and methods for targeting cancer cells |
Dec. 18, 2007 |
| 7304043 |
.beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
Dec. 4, 2007 |
| 7291603 |
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
Nov. 6, 2007 |
| 7279465 |
Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
Oct. 9, 2007 |
| 7279463 |
Triple-helix forming oligonucleotides for targeted mutagenesis |
Oct. 9, 2007 |
| 7265096 |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
Sep. 4, 2007 |
| 7262177 |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
Aug. 28, 2007 |
| 7256171 |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation |
Aug. 14, 2007 |
| 7247621 |
Antiviral phosphonate compounds and methods therefor |
Jul. 24, 2007 |
| 7244716 |
Pharmaceutical composition of antiviral agents |
Jul. 17, 2007 |
| 7211570 |
Treatment of EBV and KHSV infection |
May. 1, 2007 |
| RE39573 |
Antimutagenic compositions for treatment and prevention of photodamage to skin |
Apr. 17, 2007 |
| 7205001 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 17, 2007 |
|
|
|
